Related content

Immunohistochemical evaluation of vasopressin expresion in breast fibrocystic disease and ductal carcinoma In situ (DCIS)

By North William   Wells Wendy   Fay Michael   Mathew Rennie   Donnelly Edward   Memoli Vincent  

Endocrine Pathology, Vol. 14, Iss. 3, 2003-09 ,pp. : 257-262

Humana Press, Inc

Access to resources Recommend Favorite

The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia

By Misichronis G.   Georgopoulos N. A.   Marioli D. J.   Armeni A. K.   Katsikis I.   Piouka A. D.   Saltamavros A. D.   Roupas N. D.   Panidis D.  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 249-252

Informa Healthcare

Access to resources Recommend Favorite

Divalent cations in women with PCOS: implications for cardiovascular disease

By Muneyyirci-Delale O.   Nacharaju V. L.   Dalloul M.   Jalou S.   Rahman M.   Altura B. M.   Altura B. T.  

Gynecological Endocrinology, Vol. 15, Iss. 3, 2001-06 ,pp. : 198-201

Informa Healthcare

Access to resources Recommend Favorite

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

By Teede H.   Hutchison S.   Zoungas S.   Meyer C.  

Endocrine Journal, Vol. 30, Iss. 1, 2006-08 ,pp. : 45-53

Humana Press, Inc

Access to resources Recommend Favorite

Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?

By Dursun Polat   Demirtaş Ezgi   Bayrak Ahmet   Yarali Hakan  

Human Reproduction, Vol. 21, Iss. 1, 2006-01 ,pp. : 104-108

Oxford University Press

Access to resources Recommend Favorite